On Tuesday, January 31, 2017, President Trump nominated Neil Gorsuch from the 10th Circuit Court of Appeals to fill the vacancy on the U.S. Supreme Court. AAI President Diana Moss said, “AAI will continue to review Judge Gorsuch’s record and press the Senate to ensure any Supreme Court nominee is committed to enforcement of the antitrust laws. Such enforcement should be consistent with congressional intent throughout the past many decades, thereby ensuring the robust continuation of free and competitive markets.”
The American Antitrust Institute (AAI) filed an amicus brief in the Eleventh Circuit Court of Appeals urging the court to affirm that price-fixing overcharges on fees may not be offset by purported savings on other elements of service.
On February 8, 2017, the American Antitrust Institute will host its first International Antitrust Roundtable "Critical Issues in Global Antitrust: Comity, Intellectual Property, and Due Process." Experts from business, academia, law, and government in the U.S. and abroad will discuss major competition enforcement and policy issues on the global antitrust agenda.
The American Antitrust Institute (AAI) filed an amicus brief with a group of leading intellectual property law professors urging the Supreme Court to reverse a Federal Circuit Court of Appeals decision that sharply restricts the patent exhaustion doctrine.
Today, the AAI praised Judge John D. Bates’s opinion granting the U.S. Department of Justice (DOJ) an injunction to block the merger of health insurers Aetna and Humana. AAI President Diana Moss noted, “This is a victory for competition and consumers. The opinion sets forth a clear, logical, and understandable rationale for why the merger would have raised prices and reduced benefits to consumers in important health insurance markets.”
"Attempts by the incoming administration to broker merger deals or directly negotiate merger concessions signal a fundamental disregard for the law and for due process. Antitrust enforcers play the important role of referee in protecting competition and our market system. Every consumer, producer, competitor, and customer should be able to count on a fair, predictable, and transparent process for government review of mergers. The end-runs that we are seeing in key mergers such as Monsanto-Bayer not only abuse the process, they imperil our markets, our economy, and our society.”
- American Antitrust Institute President Diana Moss
The American Antitrust Institute and Navigant Economics are hosting a Healthcare Roundtable on Wednesday, February 22, 2017. Experts from government, academia, industry, and advocacy will gather to discuss major competition enforcement and policy issues facing the healthcare industry.
On January 6, AAI President Diana Moss joined the American Medical Association’s annual State Legislative Strategy Conference in Florida to moderate the panel "Challenges of and Remedies for a Rapidly Consolidating Healthcare Marketplace."
The AAI announced today that Eduardo Pérez Motta, former chairman of the Mexican Federal Competition Commission and former chair of the International Competition Network, will deliver the keynote luncheon address during the AAI International Antitrust Roundtable on Wednesday, February 8, in Washington, D.C. The agenda and overview are available here.
Leaders from the international antitrust community will speak at the AAI International Antitrust Roundtable on Wednesday, February 8, in Washington, D.C. The agenda and overview are available here. The confirmed speaker lineup includes: